SCHEMBL7673723

SCHEMBL7673723

COC(c1ccccc1)(c1ccccc1)C(Oc1ccc(C)nn1)C(=O)O

nearest known ligand 0.63

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ EDNRB P24530 17/20 0.63
▸ EDNRA P25101 17/20 0.63
▸ NR1I2 O75469 1/20 0.63
▸ KCNE1 P15382 1/20 0.63
▸ KCNQ1 P51787 1/20 0.63
▸ POLB P06746 1/20 0.63
▸ IL36G Q9NZH8 1/20 0.48
▸ MEN1 O00255 1/20 0.47
▸ KMT2A Q03164 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL795620 1.00 EDNRB (0.63) EDNRBEDNRANR1I2KCNE1KCNQ1
Ambrisentan SCHEMBL3679 0.77 EDNRB (1.00) EDNRBEDNRANR1I2KCNE1KCNQ1
Ambrisentan SCHEMBL138157 0.77 EDNRB (1.00) EDNRBEDNRANR1I2KCNE1KCNQ1
Ambrisentan SCHEMBL20769813 0.77 EDNRB (1.00) EDNRBEDNRANR1I2KCNE1KCNQ1
Ambrisentan SCHEMBL3023434 0.77 EDNRB (1.00) EDNRBEDNRANR1I2KCNE1KCNQ1
SCHEMBL7665087 0.76 EDNRB (0.69) EDNRBEDNRANR1I2KCNE1KCNQ1
SCHEMBL7674648 0.75 EDNRB (0.51) EDNRBEDNRANR1I2KCNE1KCNQ1
SCHEMBL8005606 0.75 EDNRB (0.61) EDNRBEDNRANR1I2KCNE1KCNQ1
SCHEMBL7934042 0.75 EDNRB (1.00) EDNRBEDNRANR1I2KCNE1KCNQ1
SCHEMBL8021756 0.74 EDNRB (0.86) EDNRBEDNRANR1I2KCNE1KCNQ1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6448248-B1 ENDOTHELIN IS INVOLVED IN A NUMBER OF ILLNESSES INCLUDING: HYPERTENSION, ACUTE MYOCARDIAL INFARCT, PULMONARY HYPERTENSION, RAYNAUD'S SYNDROME, CEREBRAL VASOSPASMS, STROKE, BENIGN PROSTATE HYPERTROPHY, ATHEROSCLEROSIS AND ASTHMA ABBOTT LABORATORIES 2002-09-10 — — US disclosed
Send feedback